低分子肝素联合卡托普利治疗肾病综合征的疗效分析

目的探讨低分子肝素联合卡托普利治疗肾病综合征的疗效。方法将58例肾病综合征随机分为2组,对照组与观察组各29例,两组患者均接受泼尼松、白蛋白、降血脂药物、利尿剂等药物治疗,观察组在上述治疗的基础上再联合使用低分子肝素、卡托普利。结果观察组的治疗效果显著优于对照组,两组比较差异有统计学意义(P<0.05)。结论在常规治疗基础上联合使用低分子肝素、卡托普利可显著提高肾病综合征患者的疗效,该方案值得在临床上推广与应用。

Objective To explore the therapeutic effect of patients with nephrotic syndrome treated with low molecular weight heparin combined with captopril.Methods 58 patients with nephrotic syndrome were divided into 2 groups randomly,and the control group and the observation group included 29 patients,respectively.All patients received prednisone,albumin,lipid-lowering drugs,diuretics,and so on.The observation group received low molecular weight heparin,captopril on the basis of the above mentioned treatment program.Results The therapeutic effect of the observation group was significantly better than that of the control group（P〈0.05）.Conclusion Low molecular weight heparin combined with captopril on the basis of conventional treatment program is able to improve the therapeutic effect of patients with nephrotic syndrome,and this treatment program is worthy of being popularized and applied.